Tilray Brands, Inc.

Tilray Brands, Inc.

2HQ0 · XETRA · Healthcare / Drug Manufacturers - Specialty & Generic

2.23EUR-0.05 (-2.20%)

Price History

Full chart

Market Stats

Previous Close2.28
Open2.27
Day Range2.20 – 2.36
52-Week Range3.21 – 18.13
Volume4.08K
Market Cap474.38M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.96
Dividend Yield0.00%
Beta1.92
50-Day Avg3.76
200-Day Avg5.50

About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Irwin David Simon
  • Employees3.60K
  • Headquarters265 Talbot Street West, Leamington, ON, Canada, N8H 5L4, Germany
  • Websitehttps://www.tilray.com

Leadership

  • Mr. Irwin David SimonPresident, CEO & Chairman · b. 1958
  • Mr. Carl A. Merton CA, CBV, CPACFO & Principal Accounting Officer · b. 1970
  • Mr. Roger SavellChief Administrative Officer & CFO of International · b. 1963
  • Mr. Mitchell S. Gendel J.D.Global General Counsel & Corporate Secretary · b. 1966
  • Ms. Denise Menikheim FaltischekChief Strategy Officer and Head of M&A · b. 1973
  • Mr. Lloyd BrathwaiteChief Information Officer
  • Ms. Nyree PintoChief Human Resources Officer
  • Ms. Berrin NoorataChief Corporate Affairs Officer
  • Mr. Blair MacNeil CMA, CPAPresident of Tilray Canada
  • Mr. Rajnish OhriPresident of International · b. 1962

Financials

Income Statement

Currency: USD2022-05-312023-05-312024-05-312025-05-312026-05-31
Total Revenue628.37M627.12M788.94M821.31M914.36M
Growth (%)--0.20%+25.80%+4.10%+11.33%
Cost of Revenue511.56M480.16M565.59M580.74M673.79M
Gross Profit116.82M146.96M223.35M240.57M240.57M
Gross Margin18.59%23.43%28.31%29.29%26.31%
Operating Expense727.22M1.52B398.10M2.52B295.26M
Operating Income-610.40M-1.37B-174.75M-2.28B-54.69M
Operating Margin-97.14%-218.41%-22.15%-277.93%-5.98%
EBITDA-246.40M-1.27B-72.84M-2.13B12.83M
EBITDA Margin-39.21%-203.06%-9.23%-259.04%1.40%
Net Income-476.80M-1.45B-244.98M-2.19B-121.25M
Net Income Margin-75.88%-231.64%-31.05%-266.25%-13.26%
R&D1.52M682.00K635.00K284.00K360.57K
R&D as % of Total Revenue0.24%0.11%0.08%0.03%0.04%
Interest Expense39.68M46.61M49.26M41.33M23.63M
Interest Expense % of Total Revenue6.31%7.43%6.24%5.03%2.58%

Balance Sheet

Currency: USD2022-05-312023-05-312024-05-312025-05-312026-05-31
Total Assets5.45B4.31B4.22B2.07B2.33B
Total Liabilities1.01B977.32M778.49M584.75M732.27M
Total Equity4.40B3.32B3.44B1.51B1.61B
Cash415.91M206.63M228.34M221.67M229.07M
Total Debt623.81M590.13M387.32M328.74M397.93M
Net Debt207.90M383.50M158.98M107.07M168.86M

Cash Flow

Currency: USD2022-05-312023-05-312024-05-312025-05-312026-05-31
Operating Cash Flow-177.26M7.91M-30.91M-94.60M-69.39M
Investing Cash Flow-21.53M-285.11M128.35M-46.72M-55.73M
Financing Cash Flow128.20M70.16M-75.19M133.51M130.84M
Capital Expenditure34.06M20.80M29.25M32.92M32.95M
Free Cash Flow-211.33M-12.89M-60.15M-127.52M-102.33M
FCF to OCF119.22%-163.09%194.64%134.80%147.48%

Earnings

Report DateDec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Aug 31, 2021Nov 30, 2021Feb 28, 2022May 31, 2022Aug 31, 2022Nov 30, 2022Feb 28, 2023May 31, 2023Aug 31, 2023Nov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Nov 30, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026May 31, 2026
EPS Estimate-------------------------
EPS Actual-19.42-15.70-5.95-0.15-0.17-0.78-0.000.78-8.32-1.24-1.14-17.83-1.95-0.95-0.63-1.13-0.37-0.41-0.91-8.34-11.72-0.00-0.35-0.20-0.37
Surprise-------------------------
Timing-------------------------

Key Statistics & Ratios

Market Cap474.38M
Enterprise Value650.78M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.52
Price / Book0.36
EPS-0.96
Book Value10.87
Revenue (TTM)915.45M
Gross Profit (TTM)262.59M
EBITDA15.00M
Profit Margin-13.26%
Operating Margin-0.83%
Return on Equity-6.82%
Return on Assets-1.49%
Shares Outstanding147.78M
Shares Float133.34M
Beta1.92
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 2, 20251:10